To answer these questions, first we tested 564 women with DCIS for the most common Polish founder mutations of BRCA1/2 (10 alleles), which account for approximately 80% of all mutations detected in these genes in Poland [26,29,30]. Here, BRCA1 is linked to ductal breast carcinoma in situ.